Foresite Capital Management IV as of Dec. 31, 2025
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 7 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pharvaris N V (PHVS) | 57.7 | $133M | 4.8M | 27.75 | |
| Cytokinetics (CYTK) | 12.7 | $29M | 458k | 63.54 | |
| Lyell Immunopharma (LYEL) | 10.7 | $25M | 800k | 30.78 | |
| Maze Therapeatics (MAZE) | 9.4 | $22M | 523k | 41.43 | |
| Relay Therapeutics (RLAY) | 3.7 | $8.5M | 1.0M | 8.46 | |
| Xenon Pharmaceuticals (XENE) | 3.1 | $7.2M | 160k | 44.82 | |
| Alector (ALEC) | 2.6 | $6.1M | 3.9M | 1.56 |
